Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
fda
8
×
life sciences
national blog main
san francisco blog main
8
×
venture capital
8
×
biotech
san diego blog main
san francisco top stories
boston top stories
indiana blog main
national top stories
new york blog main
raleigh-durham blog main
san diego top stories
seattle blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana top stories
national
new york top stories
raleigh-durham top stories
seattle top stories
startups
texas blog main
texas top stories
vc
wisconsin blog main
wisconsin top stories
clinical trials
deals
ipo
novartis
biogen
cancer
investing
scott gottlieb
takeda pharmaceutical
What
bio
roundup
ipo
million
patients
covid
developing
fda
help
medicines
new
startup
therapeutics
years
acquisitions
activity
ahead
allogene
analytics
announced
approvals
asco
beta
biofourmis
biogen
bionics
biopharma
blood
branded
cancer
car
celgene
ceo
choices
clamped
closed
collabs
colleagues
commissioner
consumers
Language
unset
Current search:
fda
×
" venture capital "
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets